New Strong Buy Stocks for December 30th

Zacks

30 Dec 2024

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

CoreCard Corporation CCRD: This technology solutions and processing services company has seen the Zacks Consensus Estimate for its current year earnings increasing 7% over the last 60 days.

CoreCard Corporation Price and Consensus

CoreCard Corporation price-consensus-chart | CoreCard Corporation Quote

Appian Corporation APPN: This software company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.

Appian Corporation Price and Consensus

Appian Corporation price-consensus-chart | Appian Corporation Quote

USANA Health Sciences, Inc. USNA: This nutritional, personal care, and skincare products company has seen the Zacks Consensus Estimate for its next year earnings increasing 12.8% over the last 60 days.

USANA Health Sciences, Inc. Price and Consensus

USANA Health Sciences, Inc. price-consensus-chart | USANA Health Sciences, Inc. Quote

Entrada Therapeutics, Inc. TRDA: This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 64.7% over the last 60 days.

Entrada Therapeutics, Inc. Price and Consensus

Entrada Therapeutics, Inc. price-consensus-chart | Entrada Therapeutics, Inc. Quote

NRx Pharmaceuticals, Inc. NRXP: This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.

NRx Pharmaceuticals, Inc. Price and Consensus

NRx Pharmaceuticals, Inc. price-consensus-chart | NRx Pharmaceuticals, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

USANA Health Sciences, Inc. (USNA) : Free Stock Analysis Report

Appian Corporation (APPN) : Free Stock Analysis Report

NRx Pharmaceuticals, Inc. (NRXP) : Free Stock Analysis Report

Entrada Therapeutics, Inc. (TRDA) : Free Stock Analysis Report

CoreCard Corporation (CCRD) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Tiger Brokers